Metabolic Health, Bones and Nuts During Weight Loss in Adults
Part of paid clinical trials in New Brunswick, New Jersey.
- Sponsor
- Rutgers, The State University of New Jersey
- Study ID
- NCT06949280
- Status
- Recruiting
Conditions
- Bone Density
- Obesity and Overweight
- Weight Loss
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - 75 Years
- Healthy Volunteers
- Accepted
Interventions
- Peanut Snack Experimental — DIETARY_SUPPLEMENTSubjects will receive a daily peanut snack and nutrition education-behavior modification instructions for weight loss
- Nut-free Snack — DIETARY_SUPPLEMENTSubjects will receive a daily peanut snack and nutrition education-behavior modification instructions for weight loss
Study Details
The aging population is rapidly increasing, and it is important to identify dietary factors that can prevent disease and promote health in this group. Legumes, such as peanuts, are a plant-based food high in protein and unsaturated fat making this a healthy choice but are not consumed frequently enough in older adults. Studies have shown that regular nut consumption is associated with lower adiposity and reduced weight gain, and several dietary pattern studies indicate that nuts and legumes are associated with better bone health. In addition, our preliminary translational data indicates that a higher monounsaturated fatty acid (MUFA) intake is associated with improved bone mineral density (BMD) and quality. Given these findings, the proposed study aims to examine the impact of consuming peanut products on bone health, metabolic health (e.g., serum glucose, insulin, lipids and inflammation), markers of brain and sleep health, and physical function in overweight and obese older adults before and after a six-month weight loss intervention using a randomized controlled design. The results of this study have the potential to provide valuable insights into the role of peanuts as a sources of fatty acids in promoting health and preventing disease in at-risk adults.
Key Dates
- Start date
- Oct 30, 2025
- Status verified
- May 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 44 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: PeanutPeanut products
- Active Comparator: Nut-free snackGrain snack (nut-free)
Primary Outcome Measure
Bone Mineral Density (BMD - hip) [ Time Frame: Change from baseline to 24 weeks ]
Central Contacts
- Principal Investigator848-932-9403
- Research Manager
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Rutgers University - NJ Inst Food Nutrition & Health | New Brunswick | New Jersey | 08901 |
Find similar trials in New Brunswick, NJ
Related Studies
- Efficacy and Safety of MET097 Once-Weekly in People With Overweight or ObesityPHASE3 · Recruiting · Pfizer · Scottsdale, Arizona
- GLP-1 Medication & Behavioral Health Programs on Weight & Metabolic Outcomes: FLOURISH and THRIVE Prospective Cohort StudyNot Yet Recruiting · Noom Inc. · Princeton, New Jersey
- Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss TreatmentPHASE2 · Recruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Phoenix, Arizona
- Bariatric Embolization of Arteries for the Treatment of Nonalcoholic SteatohepatitisNot Yet Recruiting · Keith Pereira, MD: · St Louis, Missouri